当前位置:考试网  > 试卷库  > 技能鉴定  > 服务行业  > 服务行业人员  >  简述当维修项目发生变化时作为服务顾问需要做哪些工作
试题预览

简述当维修项目发生变化时作为服务顾问需要做哪些工作

查看答案
收藏
纠错
正确答案:

尽早通知客户服务信息的变更,避免在预计交车时间前30分钟内再通知客户关于服务信息的变更确认变更的服务项目、服务费用和预计交车时间等服务信息,利用特约店运营管理系统重新制作维修委托书或者制作能够确认变更服务信息的表单

第一时间找到客户,通知在客户休息区或者在其他区域等候的客户,向客户说明服务项目、服务费用和预计交车时间等服务信息的变更原因,向客户说明立即维修增加的服务项目对车辆和客户的益处,征求客户的同意或者根据客户的需要安排其他时间再次进店维修,向客户说明变更后的维修委托书或者确认变更服务信息的表单中记录的变更的服务信息,并且请客户签字确认,向客户提示本次检查出来的但是未得到客户同意的项目,说明进行相应的维修所带来的益处和暂时不进行维修可能导致的潜在危害,并且请客户签字确认

知离店等候的客户时:以客户首选的联系方式联系客户,向客户说明服务项目、服务费用和预计交车时间等服务信息的变更原因,向客户说明立即维修增加的服务项目对车辆和客户的益处征求客户的同意或者根据客户的需要安排其他时间再次进店维修,保留聊天记录,并等客户进店时确认签字。

答案解析:

暂无解析

你可能感兴趣的试题

燃油品质差会导致三元催化系统堵塞

杯具要求明亮干净,无水迹、无手印、无破损

DMS三包预警功能中的自动提示信息,只能在客户接待画面上查询到

以下哪一个是防抱死制动系统(ABS)的部件

当接受客人吩咐时,服务员应说恩

热门试题 更多>
试题分类: 写作
练习次数:0次
试题分类: 写作
练习次数:0次
试题分类: 计算机二级
练习次数:7次
1.The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels.But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease. 2.Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib,a drug designed to raise heart-protective high-density lipoproteins (HDLs).In a trial of 15000 patients,a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 3.The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease."There have been no red flags to my knowledge," says John Chapman,a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib."This cancellation came as a complete shock." 4.Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs,which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body.Specifically,torcetrapib blocks a protein called cholesterol ester transfer protein (CETP),which normally transfers the cholesterol from high-density lipoproteins to low density,plaque-promoting ones.Statins,in contrast,mainly work by lowering the 'bad' low-density lipoproteins. Under pressure 5.Researchers are now trying to work out why and how the drug backfired,something that will not become clear until the clinical details are released by Pfizer.One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients.It was thought that this mild problem would be offset by the heart benefits of the drug.But it is possible that it actually proved fatal in some patients who already suffered high blood pressure.If blood pressure is the explanation,it would actually be good news for drug developers because it suggests that the problems are specific to this compound.Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 6.But it is also possible that the whole idea of blocking CETP is flawed,says Moti Kashyap,who directs atherosclerosis research at the VA Medical Center in Long Beach,California.When HDLs excrete cholesterol in the liver,they actually rely on LDLs for part of this process.So inhibiting CETP,which prevents the transfer of cholesterol from HDL to LDL,might actually cause an abnormal and irreversible accumulation of cholesterol in the body."You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap.Going up 7.Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients.But HDLs are complex and not entirely understood.One approved drug,called niacin,is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling.Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone.Scientists are also working on several other means to bump up high-density lipoproteins by,for example,introducing synthetic HDLs."The only thing we know is dead in the water is torcetrapib,not the whole idea of raising HDL," says Michael Miller,director of preventive cardiology at the University of Maryland Medical Center,Baltimore. Questions 7-13 Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)..Write the correct letter A,B,C or D in boxes 8-13 on your answer sheet.NB You may use any letter more than once. 7.It has been administered to over 10,000 subjects in a clinical trial. 8.It could help rid human body of cholesterol. 9.Researchers are yet to find more about it. 10.It was used to reduce the level of cholesterol. 11.According to Kashyap,it might lead to unwanted result if it's blocked. 12.It produced contradictory results in different trials. 13.It could inhibit LDLs.List of choices A.TorcetrapicB.HDLSC.StatinD.CETP
试题分类: 阅读
练习次数:3次
试题分类: 初级(口语)
练习次数:0次
试题分类: 口语
练习次数:0次
试题分类: 写作
练习次数:0次
扫一扫,手机做题